Literature DB >> 26159676

Circulating Brain-Derived Neurotrophic Factor Has Diagnostic and Prognostic Value in Traumatic Brain Injury.

Frederick K Korley1, Ramon Diaz-Arrastia2, Alan H B Wu3, John K Yue4, Geoffrey T Manley4, Haris I Sair5, Jennifer Van Eyk6, Allen D Everett7, David O Okonkwo8,9, Alex B Valadka8,10, Wayne A Gordon8,11, Andrew I R Maas8,12, Pratik Mukherjee8,13, Esther L Yuh8,13, Hester F Lingsma8,14, Ava M Puccio8,9, David M Schnyer8,15.   

Abstract

Brain-derived neurotrophic factor (BDNF) is important for neuronal survival and regeneration. We investigated the diagnostic and prognostic values of serum BDNF in traumatic brain injury (TBI). We examined serum BDNF in two independent cohorts of TBI cases presenting to the emergency departments (EDs) of the Johns Hopkins Hospital (JHH; n = 76) and San Francisco General Hospital (SFGH, n = 80), and a control group of JHH ED patients without TBI (n = 150). Findings were subsequently validated in the prospective, multi-center Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) Pilot study (n = 159). We investigated the association between BDNF, glial fibrillary acidic protein (GFAP), and ubiquitin C-terminal hydrolase-L1 (UCH-L1) and recovery from TBI at 6 months in the TRACK-TBI Pilot cohort. Incomplete recovery was defined as having either post-concussive syndrome or a Glasgow Outcome Scale Extended score <8 at 6 months. Median day-of-injury BDNF concentrations (ng/mL) were lower among TBI cases (JHH TBI, 17.5 and SFGH TBI, 13.8) than in JHH controls (60.3; p = 0.0001). Among TRACK-TBI Pilot subjects, median BDNF concentrations (ng/mL) were higher in mild (8.3) than in moderate (4.3) or severe TBI (4.0; p = 0.004. In the TRACK-TBI cohort, the 75 (71.4%) subjects with very low BDNF values (i.e., <the 1st percentile for non-TBI controls, <14.2 ng/mL) had higher odds of incomplete recovery than those who did not have very low values (odds ratio, 4.0; 95% confidence interval [CI]: 1.5-11.0). The area under the receiver operator curve for discriminating complete and incomplete recovery was 0.65 (95% CI: 0.52-0.78) for BDNF, 0.61 (95% CI: 0.49-0.73) for GFAP, and 0.55 (95% CI: 0.43-0.66) for UCH-L1. The addition of GFAP/UCH-L1 to BDNF did not improve outcome prediction significantly. Day-of-injury serum BDNF is associated with TBI diagnosis and also provides 6-month prognostic information regarding recovery from TBI. Thus, day-of-injury BDNF values may aid in TBI risk stratification.

Entities:  

Keywords:  biomarkers; brain-derived neurotrophic factor; glial fibrillary acidic protein; traumatic brain injury; ubiquitin C-terminal hydrolase-L1

Mesh:

Substances:

Year:  2015        PMID: 26159676      PMCID: PMC4722554          DOI: 10.1089/neu.2015.3949

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  66 in total

Review 1.  Neurotrophins: roles in neuronal development and function.

Authors:  E J Huang; L F Reichardt
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

2.  Validation of the 99th percentile cutoff independent of assay imprecision (CV) for cardiac troponin monitoring for ruling out myocardial infarction.

Authors:  Fred S Apple; Curtis A Parvin; Kenneth F Buechler; Robert H Christenson; Alan H B Wu; Allan S Jaffe
Journal:  Clin Chem       Date:  2005-11       Impact factor: 8.327

Review 3.  Common data elements in radiologic imaging of traumatic brain injury.

Authors:  Ann-Christine Duhaime; Alisa D Gean; E Mark Haacke; Ramona Hicks; Max Wintermark; Pratik Mukherjee; David Brody; Lawrence Latour; Gerard Riedy
Journal:  Arch Phys Med Rehabil       Date:  2010-11       Impact factor: 3.966

Review 4.  Brain-derived neurotrophic factor in traumatic brain injury, post-traumatic stress disorder, and their comorbid conditions: role in pathogenesis and treatment.

Authors:  Gary B Kaplan; Jennifer J Vasterling; Priyanka C Vedak
Journal:  Behav Pharmacol       Date:  2010-09       Impact factor: 2.293

Review 5.  Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood.

Authors:  Henrik Zetterberg; Douglas H Smith; Kaj Blennow
Journal:  Nat Rev Neurol       Date:  2013-02-12       Impact factor: 42.937

6.  Troponin elevations only detected with a high-sensitivity assay: clinical correlations and prognostic significance.

Authors:  Frederick K Korley; Steven P Schulman; Lori J Sokoll; Andrew P DeFilippis; Andrew I Stolbach; Jamil D Bayram; Mustapha O Saheed; Rodney Omron; Christopher Fernandez; Albert Lwin; Stephen S Cai; Wendy S Post; Allan S Jaffe
Journal:  Acad Emerg Med       Date:  2014-08-11       Impact factor: 3.451

7.  BDNF secretion by human pulmonary artery endothelial cells in response to hypoxia.

Authors:  Martin Helan; Bharathi Aravamudan; William R Hartman; Michael A Thompson; Bruce D Johnson; Christina M Pabelick; Y S Prakash
Journal:  J Mol Cell Cardiol       Date:  2014-01-23       Impact factor: 5.000

8.  Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets.

Authors:  Félicien Karege; Michèle Schwald; Mbaye Cisse
Journal:  Neurosci Lett       Date:  2002-08-16       Impact factor: 3.046

9.  Nerve growth factor expression correlates with severity and outcome of traumatic brain injury in children.

Authors:  Antonio Chiaretti; Alessia Antonelli; Riccardo Riccardi; Orazio Genovese; Patrizio Pezzotti; Concezio Di Rocco; Luca Tortorolo; Giovanni Piedimonte
Journal:  Eur J Paediatr Neurol       Date:  2007-09-18       Impact factor: 3.140

10.  Transforming research and clinical knowledge in traumatic brain injury pilot: multicenter implementation of the common data elements for traumatic brain injury.

Authors:  John K Yue; Mary J Vassar; Hester F Lingsma; Shelly R Cooper; David O Okonkwo; Alex B Valadka; Wayne A Gordon; Andrew I R Maas; Pratik Mukherjee; Esther L Yuh; Ava M Puccio; David M Schnyer; Geoffrey T Manley
Journal:  J Neurotrauma       Date:  2013-09-24       Impact factor: 5.269

View more
  49 in total

1.  Head injury serum markers for assessing response to trauma: Design of the HeadSMART study.

Authors:  Matthew E Peters; Vani Rao; Kathleen T Bechtold; Durga Roy; Haris I Sair; Jeannie-Marie Leoutsakos; Ramon Diaz-Arrastia; Robert D Stevens; D Scott Batty; Hayley Falk; Christopher Fernandez; Uju Ofoche; Alexandra Vassila; Anna J Hall; Braden Anderson; Edward Bessman; Constantine G Lyketsos; Allen D Everett; Jennifer Van Eyk; Frederick K Korley
Journal:  Brain Inj       Date:  2017-01-31       Impact factor: 2.311

Review 2.  Fluid biomarkers for mild traumatic brain injury and related conditions.

Authors:  Henrik Zetterberg; Kaj Blennow
Journal:  Nat Rev Neurol       Date:  2016-09-16       Impact factor: 42.937

3.  Low Serum Levels of Brain-Derived Neurotrophic Factor Were Associated with Poor Short-Term Functional Outcome and Mortality in Acute Ischemic Stroke.

Authors:  Jing Wang; Li Gao; Yan-Long Yang; Yu-Qian Li; Tao Chang; Ming-Hao Man; Xing-Ye Zhang; Shao-Chun Guo; Li-Hong Li
Journal:  Mol Neurobiol       Date:  2016-11-04       Impact factor: 5.590

4.  Brain-derived neurotrophic factor levels in pediatric sickle cell disease.

Authors:  Eboni I Lance; Emily Barron-Casella; Allen D Everett; James F Casella
Journal:  Pediatr Blood Cancer       Date:  2019-11-17       Impact factor: 3.167

Review 5.  Neurochemical biomarkers in spinal cord injury.

Authors:  Brian K Kwon; Ona Bloom; Ina-Beate Wanner; Armin Curt; Jan M Schwab; James Fawcett; Kevin K Wang
Journal:  Spinal Cord       Date:  2019-07-04       Impact factor: 2.772

Review 6.  Neuroimaging of traumatic brain injury in military personnel: An overview.

Authors:  Avnish Bhattrai; Andrei Irimia; John Darrell Van Horn
Journal:  J Clin Neurosci       Date:  2019-07-19       Impact factor: 1.961

7.  Extended Solution Gate OFET-based Biosensor for Label-free Glial Fibrillary Acidic Protein Detection with Polyethylene Glycol-Containing Bioreceptor Layer.

Authors:  Jian Song; Jennifer Dailey; Hui Li; Hyun-June Jang; Pengfei Zhang; Jeff Tza-Huei Wang; Allen D Everett; Howard E Katz
Journal:  Adv Funct Mater       Date:  2017-03-23       Impact factor: 18.808

8.  Post-mortem in situ stability of serum markers of cerebral damage and acute phase response.

Authors:  Benjamin Ondruschka; Lina Woydt; Michael Bernhard; Heike Franke; Holger Kirsten; Sabine Löffler; Dirk Pohlers; Niels Hammer; Jan Dreßler
Journal:  Int J Legal Med       Date:  2018-08-30       Impact factor: 2.686

9.  Variation in Candidate Traumatic Brain Injury Biomarker Genes Are Associated with Gross Neurological Outcomes after Severe Traumatic Brain Injury.

Authors:  Nicole D Osier; Yvette P Conley; David O Okonkwo; Ava M Puccio
Journal:  J Neurotrauma       Date:  2018-09-14       Impact factor: 5.269

10.  New method to induce mild traumatic brain injury in rodents produces differential outcomes in female and male Sprague Dawley rats.

Authors:  Peter Wirth; Waylin Yu; Amanda L Kimball; Jennifer Liao; Paul Berkner; Melissa J Glenn
Journal:  J Neurosci Methods       Date:  2017-08-02       Impact factor: 2.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.